Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LENVATINIB vs LETAIRIS: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LENVATINIB vs LETAIRIS: Safety Overview

Metric LENVATINIB LETAIRIS
Total FAERS Reports 33,766 4,304
Deaths Reported 4,449 496
Death Rate 13.2% 11.5%
Hospitalizations 19,975 1,492
Average Patient Age 65.4 yrs 62.6 yrs
% Female Patients 55.8% N/A
FDA Approval Date Feb 13, 2015 N/A
Manufacturer Eisai Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A